Good evening :)
Place Order
Add to Watchlist

Innova Captab Ltd

INNOVACAP

Innova Captab Ltd

INNOVACAP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,044 cr, stock is ranked 731
Moderate RiskStock is 2.95x as volatile as Nifty
1,056.208.28% (+80.80)
1,056.208.28% (+80.80)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,044 cr, stock is ranked 731
Moderate RiskStock is 2.95x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,044 cr, stock is ranked 731
Moderate RiskStock is 2.95x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
51.087.27
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.496.670.52%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Innova Captab Ltd is an integrated pharmaceutical company involved in manufacturing and trading drugs, offering services across R&D, manufacturing, and distribution of generic formulations and branded generics.

Investor Presentation

View older 

Nov 7, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 25.17%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.16% to 0.29%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 36.55%, vs industry avg of 15.28%

Loading...

Financial YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue356.03374.62412.03803.41935.581,093.801,189.96
Raw Materialssubtract283.41291.55309.06612.42552.46582.671,003.01
Power & Fuel Costsubtract4.185.545.487.919.5120.39
Employee Costsubtract18.1020.2422.3340.4654.8090.66
Selling & Administrative Expensessubtract6.547.6110.3216.0529.6140.13
Operating & Other expensessubtract2.79-2.558.9927.67166.36193.01
Depreciation/Amortizationsubtract10.6710.085.597.5011.0815.9618.18
Interest & Other Itemssubtract5.584.633.935.6819.9721.467.90
Taxes & Other Itemssubtract4.899.6511.8521.7723.8435.1842.55
EPS165.5811.337.1824.2225.7417.9320.68
DPS0.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025

Annual Report Pending

Investor Presentation

Nov 7PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Innova Captab Ltd64.077.27
Sun Pharmaceutical Industries Ltd46.136.580.73%
Cipla Ltd29.214.490.87%
Mankind Pharma Ltd62.9112.57

Price Comparison

Compare INNOVACAP with any stock or ETF
Compare INNOVACAP with any stock or ETF
INNOVACAP
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding50.90%11.37%9.23%1.01%27.48%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%3.57%3.57%1.94%1.19%1.01%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Innova Captab Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Kotak Multicap Fund - Growth - Direct Plan

Growth
3.2811%1.16%0.34%54/72 (+2)
Canara Robeco Small Cap Fund - Growth - Direct Plan

Growth
2.9022%1.30%0.45%16/104 (+77)
Invesco India Midcap Fund - Growth - Direct Plan

Growth
1.5958%1.52%0.49%32/59 (+12)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

INNOVACAP has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Innova Captab consolidated net profit rises 52.77% in the September 2024 quarter

Net profit of Innova Captab rose 52.77% to Rs 35.00 crore in the quarter ended September 2024 as against Rs 22.91 crore during the previous quarter ended September 2023. Sales rose 12.46% to Rs 318.20 crore in the quarter ended September 2024 as against Rs 282.94 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales318.20282.94 12 OPM %15.6314.31 - PBDT51.8035.01 48 PBT46.8130.18 55 NP35.0022.91 53 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Innova Captab to announce Quarterly Result

Innova Captab will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Innova Captab to hold AGM

Innova Captab announced that the 20th Annual General Meeting (AGM) of the company will be held on 18 September 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Innova Captab consolidated net profit rises 67.60% in the June 2024 quarter

Net profit of Innova Captab rose 67.60% to Rs 29.48 crore in the quarter ended June 2024 as against Rs 17.59 crore during the previous quarter ended June 2023. Sales rose 26.17% to Rs 294.27 crore in the quarter ended June 2024 as against Rs 233.24 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales294.27233.24 26 OPM %14.3313.42 - PBDT44.1627.39 61 PBT39.3124.60 60 NP29.4817.59 68 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Innova Captab to discuss results

Innova Captab will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live